TMCnet News
National Survey Reveals Reactive Acne Treatment Persists, Despite Emotional Struggle Associated with BreakoutsGalderma Laboratories, L.P. today announced results of a new national survey that revealed more than 1,000 teens and young adults who have experienced acne struggle emotionally with their breakouts, yet treat it reactively and are anxious for results and effective acne treatments without ever visiting a dermatologist or primary care physician (PCP). This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160428005525/en/ National survey finds those who suffer from acne struggle emotionally with their breakouts, yet many don't visit their physician to discuss treatment options. (Graphic: Business Wire) "Acne can widely impact teens and young adults, especially on an emotional level, yet many only treat their acne reactively and expect immediate results," said Dr. Dendy Engelman, NYC-based board-certified dermatologist and Galderma consultant. "Acne sufferers have options, including prescription treatment options for patients with acne ranging from mild to moderate to severe inflammatory acne." A national survey* of more than 1,000 teens and young adult acne sufferers revealed that:
It's important to recognize that if acne sufferers haven't experienced improvement within two weeks after using an OTC treatment, it may be time to visit a physician to discuss prescription treatment options. One option from Galderma inclues Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% that combines two antibiotic-free medicines in one gel. Epiduo Forte Gel is the first combination of these strengths of the retinoid, adapalene, and benzoyl peroxide, proven to help control moderate to severe inflammatory acne. Another option from Galderma, Epiduo (adapalene and benzoyl peroxide) Gel, 0.1%/2.5% is the #1 prescribed branded topical acne agent in the world, using two antibiotic-free medicines for the treatment of acne. For patients with mild to moderate acne, Epiduo Gel works to help treat current breakouts quickly and help prevent future pimples from forming. Important Safety Information Indication: Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% is indicated for the topical treatment of acne vulgaris. Adverse Events: In the pivotal study, the most commonly reported adverse reactions (=1%) in patients treated with Epiduo Forte Gel were skin irritation, eczema, atopic dermatitis and skin burning sensation. Warnings/Precautions: Patients using Epiduo Forte Gel should avoid exposure to sunlight and sunlamps and wear sunscreen when sun exposure cannot be avoided. Erythema, scaling, dryness, stinging/burning, irritant and allergic contact dermatitis may occur with use of Epiduo Forte Gel and may necessitate discontinuation. When applying Epiduo Forte Gel, care should be taken to avoid the eyes, lips and mucous membranes. Important Safety Information Indication: EPIDUO® Gel is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (=1%) in patients treated with EPIDUO® Gel were dry skin, contact dermatitis, application site burning, application site irritation and skin irritation. Warnings/Precautions: Patients taking EPIDUO® Gel should avoid exposure to sunlight and sunlamps and wear sunscreen when sun exposure cannot be avoided. Erythema, scaling, dryness, stinging/ burning, irritant and allergic contact dermatitis may occur with use of EPIDUO® Gel and may necessitate discontinuation. Additional information on Epiduo Forte Gel and Epiduo Gel can be found in the prescribing information at www.epiduoforte.com and www.epiduo.com. About Acne Acne is the most common skin condition in the United States, affecting more than 40 to 50 million people.3 Acne appears when pores clog with dead skin cells,3 and can have a wide-ranging negative impact on sufferers that includes both emotional and physical scars.4 Studies show that many people who have acne suffer from low self-esteem and depression,4 and that teens who believe they have "bad" acne were more likely to think about hurting themselves.4 Acne not only affects teenagers but also can be seen in men and women of all ages3 with research showing that the onset of acne is frequently seen in prepubescent patients.5 When it comes to acne treatment, long-term use of antibiotics may be a contributing factor to the overall global antibiotic resistance issue.6 Propionibacterium acnes (P. acnes), a bacteria linked to acne, is increasingly becoming resistant to topical and oral antibiotics,6 which may potentially cause a decrease in treatment efficacy against acne.6 About Galderma Dating back to 1961, Galderma is now present in over 100 countries with an extensive product portfolio to treat a range of dermatological conditions. The company partners with health care professionals around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin, hair and nails. Strategic brands in the U.S. include Epiduo® Gel, Epiduo® Forte Gel, Oracea® Capsules, Clobex® Spray, Differin® Gel, Mirvaso® Gel, MetroGel® Gel, Soolantra® Cream, Vectical® Cream, Tri-Luma® Cream, Cetaphil®, Benzac® Acne Solutions, Restylane®, Restylane® Silk, Restylane® Lyft, Dysport® (abobotulinumtoxinA) and Sculptra® Aesthetic. All trademarks are the property of their respective owners. *The online survey, fielded in May 2015 among 1,000+ teens and young adults 13-22 years of age who have had acne and tried at least one OTC acne treatment, was developed by Galderma Laboratories, L.P with Kelton, using an email invitation. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. References
View source version on businesswire.com: http://www.businesswire.com/news/home/20160428005525/en/ |